You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A NEW SYSTEM FOR ULTRASONIC ASSESSMENT OF THE CALCANEUS

    SBC: CYBERLOGIC INC            Topic: NIAMS

    DESCRIPTION provided by applicant This Lab to Marketplace SBIR Phase I Phase II Fast Track Application has as its long term objective to establish ultrasound as a safe effective and non invasive method for assessing fracture risk an important component in clinical management of osteoporosis Osteoporosis afflicts over million people in the U S and is responsible for more than h ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. New toolkit to visualize RNAs in living cells

    SBC: LUCERNA INC            Topic: 101

    DESCRIPTION provided by applicant Over the past years it has become increasingly apparent that there is exceptional complexity in the RNA population in cells This diverse RNA pool includes microRNAs Piwi interacting RNAs termini associated RNAs and other noncoding RNAs In many cases alterations in these RNAs or proteins that bind to these RNAs have been linked to a wide range of medi ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis

    SBC: Innovimmune Biotherapeutics Holding, LLC            Topic: NIAID

    DESCRIPTION provided by applicant There are unmet medical needs in the limited biologic therapeutics for adults with rheumatoid arthritis RA associated with $ billion annual US health care and societal costs These are due to inadequate efficacy prohibitive costs poor adherence and safety issues infections andamp malignancies Oral small molecule based therapies are warranted due to ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Mindfulness and Acceptance Applied in Colleges Through Web-Based Guided Self-Help

    SBC: CONTEXTUAL CHANGE, LLC            Topic: 213

    DESCRIPTION provided by applicant Nearly half of all college students have a diagnosable mental health problem Blanco et al College counseling centers CCCs are faced with increasing demands for services from Universities students and parents to meet the treatment needs of their students Kay and Schwartz in the context of increasingly severe cases and declining resources ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Improving animal-to-human predictability in clinical trials of mental disorder

    SBC: CERTERRA, INC.            Topic: 101

    DESCRIPTION provided by applicant Huge investments in pharmaceutical research and development over the past two decades have not produced many new drugs to help treat serious neuropsychiatric diseases The increasing failure rate for new drugs at all phases of clinical trials is at least partially to blame for this productivity crisis Despite extensive precinical testing the drugs either fail ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. The Potential to Immunocloak Renal Allografts

    SBC: BREONICS, INC.            Topic: NIAID

    DESCRIPTION provided by applicant The focus of this project is a novel immunomodifying therapy that provides protection from early allograft rejection in the absence of the standard toxic systemic immunosuppressive drug regimens This novel therapy is a nano barrier membrane called NB LVF consisting of a matrix made of laminin vitrogen fibronectin and type IV collagen NB LVF is applied to ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Science Take-Out Kits for Environmental Health Education

    SBC: Science Take-Out, LLC            Topic: NIEHS

    DESCRIPTION provided by applicant Nearly percent of death and disease worldwide is linked to environmental factors WHO therefore it is critical that the general public has basic understanding of how the environment affects their health and how they might protect themselves against environmental exposures Unfortunately environmental health content is typically covered on a very ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Noninvasive Total Hemoglobin Monitor

    SBC: Kestrel Labs Inc            Topic: NHLBI

    DESCRIPTION provided by applicant It is a rare event when new and useful medical parameters can be added to the suite of monitoring and diagnostic tests available in a clinical setting Of particular importance is the ability to measure crucial physiological parameters or analyses in a continuous and noninvasive manner evidenced by the importance of noninvasive vital signs monitoring because it ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Engineering Escherichia coli for sialylation of therapeutic proteins

    SBC: Glycobia, Inc.            Topic: 300

    DESCRIPTION provided by applicant Glycoengineering is a clinically validated strategy to enhance the therapeutic properties of protein and peptide drugs This strategy involves the attachment and manipulation of carbohydrates i e glycans to improve the stability solubility serum half life and activity of these drugs A key factor in most glycoengineering is the inclusio of terminal siali ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. High throughput RNAi based functional genomics in primary cells and in vivo

    SBC: ADVANCED RNA TECHNOLOGIES, LLC            Topic: 172

    DESCRIPTION provided by applicant Completion of the HGP human genome program has opened the andapos Genomic Eraandapos in biomedical research and enables functional genomics analysis of various gene elements The long term goal of the ENCODE Project is to identify and functionally characterize all of the sequence based genomic elements Functional elements that have been studied in ENCODE in ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government